Information Journal Paper
APA:
Copy. (2017). The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment. DRUG SAFETY, 40(12), 1205-1218. SID. https://sid.ir/paper/769808/en
Vancouver:
Copy. The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment. DRUG SAFETY[Internet]. 2017;40(12):1205-1218. Available from: https://sid.ir/paper/769808/en
IEEE:
Copy, “The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment,” DRUG SAFETY, vol. 40, no. 12, pp. 1205–1218, 2017, [Online]. Available: https://sid.ir/paper/769808/en